Biological evaluation of medical devices --
|
|
- Kristin Simmons
- 6 years ago
- Views:
Transcription
1 Translated English of Chinese Standard: GB/T Translated by: Wayne Zheng et al. ICS C 30 NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA GB/T / ISO : 2009 Replacing GB/T Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process 医疗器械生物学评价第 1 部分 : 风险管理过程中的评价与试验 (ISO : 2009, IDT) Issued on: June 16, 2011 Implemented on: November 01, 2011 Issued by: General Administration of Quality Supervision, Inspection and Quarantine of the People s Republic of China; Standardization Administration of the People s Republic of China Page 1 of 38
2 Table of Contents Foreword... 3 Introduction Scope Normative references Terms and definitions General principles applying to biological evaluation of medical devices Classification of medical devices Biological evaluation process Interpretation of biological evaluation data and overall biological safety assessment Annex A (Informative) Biological evaluation trial Annex B (Informative) Guidance of risk management process Annex C (Informative) Suggested procedure for document review Bibliography Translation References and Original Chinese Standard Page 2 of 38
3 Foreword GB/T Biological evaluation of medical devices consists of following parts: Part 1: Evaluation and testing within a risk management process; Part 2: Animal welfare requirements; Part 3: Tests for genotoxicity carcinogenicity and reproductive toxicity; Part 4: Selection of trial for interactions with blood; Part 5: Test for in-vitro cytotoxicity; Part 6: Tests for local effects after implantation; Part 7: Ethylene oxide sterilization residuals; Part 9: Framework for identification and quantification of potential degradation products; Part 10: Tests for irritation and delayed-type hypersensitivity; Part 11: Tests for systemic toxicity; Part 12: Sample preparation and reference materials; Part 13: Identification and quantification of degradation products from polymeric medical devices; Part 14: Identification and quantification of degradation products from ceramics; Part 15: Identification and quantification of degradation products from metals and alloys; Part 16: Toxicokinetic study design for degradation products and leachables; Part 17: Establishment of allowable limits for leachable substances; This Part is Part 1 of GB/T There are other standards for biological trial in other aspects. This Part is drafted according to the rules specified in GB/T This Part replaces GB/T Biological Evaluation of Medical Devices -- Part 1: Evaluation and Test. Compared with GB/T , the main contents modified are as follows: Modified the name of the Standard; Page 3 of 38
4 cytotoxicity (ISO : 1999, IDT) GB/T Biological evaluation of medical devices -- Part 6: Tests for local effects after implantation (ISO : 1994, IDT) GB/T Biological evaluation of medical devices -- Part 7: Ethylene oxide sterilization residuals (ISO : 2995, IDT) GB/T Biological evaluation of medical devices -- Part 9: Framework for identification and quantification of potential degradation products (ISO : 1999, IDT) GB/T Biological evaluation of medical devices -- Part 10: Tests for irritation and delayed-type hypersensitivity (ISO : 2002, IDT) GB/T Biological evaluation of medical devices -- Part 11: Tests for systemic toxicity (ISO : 1993, IDT) GB/T Biological evaluation of medical devices -- Part 12: Sample preparation and reference materials (ISO : 2002, IDT) GB/T Biogical evaluation of medical devices -- Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO : 1998, IDT) GB/T Biological evaluation of medical devices -- Part 14: Identification and quantification of degradation products from ceramics (ISO : 2001, IDT) GB/T Biological evaluation of medical devices -- Part 15: Identification and quantification of degradation products from metals and alloys (ISO : 2000, IDT) GB/T Biological evaluation of medical devices -- Part 16: Toxicokinetic study design for degradation products and leachables (ISO : 2000, IDT) GB/T Biological evaluation of medical devices -- Part 17: Establishment of allowable limits for leachable substances (ISO : 2002, IDT) YY/T Medical devices -- Application of risk management to medical devices (ISO 14971: 2007, IDT) This Part is proposed by SFDA (State Food and Drug Administration) This Part is under the jurisdiction of National Technical Committee (SAC/TC 248) on Page 5 of 38
5 Biological Evaluation on Medical Device of Standardization Administration of China. The responsible drafting organization is Jinan Medical Device Quality Supervision Inspection Centre of SFDA. The chief drafting staffs of this Part include Wu Ping, You Shaohua and Liu Chenghu. This Part replaces the following historical editions: GB/T ; GB/T Page 6 of 38
6 Introduction The primary aim of this Part of GB/T / ISO is to protect humans from potential biological risks arising from the use of medical devices. This Part is compiled from numerous International and National Standards and Guidelines concerning the biological evaluation of medical devices. It is intended to be a guiding document for the biological evaluation of medical devices for risk management process (as part of overall evaluation and development process for various medical devices). This approach combines the review and evaluation of existing data from all sources with, where necessary, the selection and application of additional trial, so that to perform holistic biological evaluation to the usage safety of various medical devices. It must be appreciated that the term medical device has wide-ranging meaning, it may be consisted of a single material which may be existed in more than one physical form, it may also be consisted of complex instruments which are consisted of multiple components or apparatus components made of multiple materials. GB/T / ISO addresses the determination of the effects of medical devices on tissues, under general condition, it does not involve device of special application. Thus, for a complete biological safety evaluation, it classifies medical devices according to the nature and duration of their anticipated contact with human tissues when in use. It indicates, in matrices, the biological data sets that need to be considered by various medical devices. The range of biological hazards is wide and complex. When considering the mutual interaction between tissue and composing material, it cannot be isolated from the overall device design. Thus, in designing a device, choosing the best material with respect to its tissue interaction may not necessarily result good performance of device, the interaction between tissue and material is only one of the characteristics to be considered in making that choice. When implementing device s function, biological evaluation must involve the mutual interaction between the material prediction and tissue. Tissue interactions refer to the adverse reaction caused by a material under the specific application, it might not occur un other applications. Biological trial is usually based upon Page 7 of 38
7 in-vitro and semi-vivo trial methods and animal models, it cannot unequivocally conclude that the same reaction will also occur in human body. Therefore, it can only be shown in the form of caution to judge the predicted effect when the device is used in human body. In addition, different individuals may respond differently to the same material, it indicates that some patients can have adverse reactions even to well-established materials. The role of this Part is to provide framework for planning biological evaluation of medical device. Along with the scientific knowledge advancement and understanding of the basic mechanisms of tissue responses, under the conditions that it is possible to obtain the same relevant information as in-vivo model, it shall preferably adopt chemical analysis trial and in-vitro model, so as the quantity of tested animals is minimized. GB/T / ISO do not intent to rigidly specify a set of test methods, including pass/fail criteria. As this might result in 2 possibilities. One of the possibilities is that development and application of new medical device may be unnecessarily restrained, another possibility is that a false sense of security may be generated by using the medical device. Under the condition that some special applications have been proved, experts from manufacturing area or usage area may establish special trials and indicators in specific product standard. This Part is intended for use by professionals who have been trained and with practical experience. Under the circumstance that considering device s all relevant factors, specific application, scientific document evaluation and up-to-date knowledge of medical device provided by historical clinical experience, they are able to interpret the standard s requirements and conduct the judgment to evaluation result of device. Annex A contains an informative table, it is generally used to identify biological data sets recommended in the evaluation of medical devices, according to the contact class and clinical contact duration of human body and medical device. Annex B contains application guidance of medical device s risk management process related to biological evaluation. Page 8 of 38
8 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process 1 Scope This Part of GB/T describes: -- The general principles governing the biological evaluation of medical devices within a risk management process; -- The general classification of devices based on the nature and duration of their contact with the body; -- The evaluation of existing relevant data from all sources; -- The identification of gaps in the available data set on the basis of a risk analysis; -- The identification of additional data sets necessary to analyze the biological safety of the medical device; -- The assessment of the biological safety of the medical device. This Part does not cover trial of materials and devices that do not come into direct or indirect contact with the patient's body, nor does it cover biological hazards arising from any mechanical failure. Other parts of GB/T cover specific trial, as indicated in the Foreword. 2 Normative references The articles contained in the following documents have become part of this Part when they are quoted herein. For the dated documents so quoted, all the modifications (Including all corrections) or revisions made thereafter shall be applicable to this Part. ISO Biological evaluation of medical devices -- Part 2: Animal welfare requirements ISO Biological evaluation of medical devices -- Part 3: Tests for genotoxicity, Page 9 of 38
9 carcinogenicity and reproductive toxicity ISO Biological evaluation of medical devices -- Part 4: Selection of trial for interaction with blood ISO Biological evaluation of medical devices -- Part 5: Tests for in-vitro cytotoxicity ISO Biological evaluation of medical devices -- Part 6: Tests for local effects after implantation ISO Biological evaluation of medical devices -- Part 7: Ethylene oxide sterilization residuals ISO Biological evaluation of medical devices -- Part 9: Framework for identification and quantification of potential degradation products ISO Biological evaluation of medical devices -- Part 10: Tests for irritation and skin sensitization ISO Biological evaluation of medical devices -- Part 11: Tests for systemic toxicity ISO Biological evaluation of medical devices -- Part 12: Sample preparation and reference materials ISO Biological evaluation of medical devices -- Part 13: Identification and quantification of degradation products from polymeric medical devices ISO Biological evaluation of medical devices -- Part 14: Identification and quantification of degradation products from ceramics ISO Biological evaluation of medical devices -- Part 15: Identification and quantification of degradation products from metals and alloys ISO Biological evaluation of medical devices -- Part 16: Toxicokinetic study design for degradation products and leachables ISO Biological evaluation of medical devices -- Part 17: Establishment of allowable limits for leachable substances ISO : 2005 Biological evaluation of medical devices -- Part 18: Chemical characterization of materials Page 10 of 38
10 ISO/TS Biological evaluation of medical devices -- Part 19: Physico-chemical, morphological and topographical characterization of materials ISO/TS Biological evaluation of medical devices -- Part 20: Principles and methods for immunotoxicology testing of medical devices ISO Medical Devices -- Application of risk management to medical devices 3 Terms and definitions For the purpose of this Part, the following terms and definitions shall apply. 3.1 medical device Any instrument, apparatus, implement, machine, appliance, implant, in-vitro reagent or calibrator, software, material, or other similar or related article, intended by the manufacturer to be used, alone or in combination, for human beings for one or more of the specific purpose(s) of: -- Diagnosis, prevention, monitoring, treatment or alleviation of disease, -- Diagnosis, monitoring, treatment, alleviation of or compensation for an injury, -- Investigation, replacement, modification, or support of the anatomy or of a physiological process, -- Supporting or sustaining life, -- Control of conception, -- Disinfection of medical devices, -- Providing information for medical purposes by means of in-vitro examination of specimens derived from the human body. It does not achieve its primary design effect in or on the human body by pharmacological, immunological or metabolic means, but which may be assisted in its function by such means. NOTE 1: This definition has been developed by the Global Harmonization Task Force (GHTF). [YY/T , definition 3.7] NOTE 2: Products which might be considered to be medical devices in some jurisdictions but for which there is not yet a harmonized approach, are: Page 11 of 38
11 (see ISO ). Such trials, including pyrogenicity trial, are used to detect material-property pyrogenic reactions of extracts of medical devices or materials. Single test can not differentiate if pyrogenic reaction is caused by material-property or by endotoxin contamination. If feasible, acute systemic toxicity trial may be combined with sub-acute and sub-chronic toxicity and implanted into trial program Sub-acute and sub-chronic toxicity It shall adopt sub-acute and sub-chronic toxicity trials to determine the effects of medical device with single or multiple effects or contact, materials and (or) their extracts, within a period greater than 24 h to a period not greater than 10 % of the total life-span of the tested animal (e.g. up to 13 weeks for rats). If available chronic toxicity data of the relevant materials are sufficient to evaluate the sub-acute and sub-chronic toxicity, it shall avoid to conduct such trial. The reason for waiving of the trial shall be included in the overall biological evaluation report. These trials shall adapt to the contact route and contact duration of device or material. Sub-acute trial and sub-chronic toxicity trial are given in ISO If feasible, sub-acute and sub-chronic systemic toxicity trial program may be extended to include implantation trial program, so as to evaluate sub-acute, sub-chronic systemic and local effects Genotoxicity It shall utilize a group of in-vitro genotoxicity trial, and use mammalian or non-mammalian cell culture or other techniques to determine gene mutations, changes of chromosome structure and quantity, and other DNA or gene toxicities caused by medical devices, materials and (or) their extracts. If in-vitro trial shows positive, it shall perform in-vivo mutagenicity trial, otherwise it shall infer that the material is mutagenic (see ISO ) Implantation It shall utilize implantation trial, under eye s inspection and microscopic inspection, to evaluate the local pathological effects of living tissue. It shall apply surgical method to Page 23 of 38
12 The document review shall state the sources of document and data, searching range of database or other information compilation. C.2.4 Assessment of document Document review shall clearly assess the quality of the document, it shall consider the intended usage of the device to evaluate the relation degree between the document AND feature and characterization of the considered material and device. The following factors shall be considered: a) Similarity between the device in the selected documents AND the device under consideration - based on process, critical performance, design and principles of operation, so as to evaluate document applicability; b) Relevance between particular experimental animals used in the selected studies AND biological evaluation of the device under consideration; c) Usage condition of the material or device in the selected documents and the intended use of the device under consideration. C.2.5 Evaluation of importance of document Document review shall evaluate the significance and weightage to studies of different designs AND published and unpublished data. If unpublished data is included in the assessment, the document review shall identify the significance and attach the data. Evaluation factors of importance shall include: -- Whether the author's conclusions can be confirmed by available data; -- Whether the document reflects the current medical practice and technical level; -- Whether references are taken from recognized scientific publications and whether they have been reported by peer reviewed journals; -- The extent to which the published document is derived from research result which complies with one or more scientific principles. The document review shall include evaluation of importance of document. After documents are obtained and assessed, the applicable selection criteria and the exclusion of any document from the importance evaluation shall be demonstrated. Before completing the document evaluation of considered device and its intended usage, it shall Page 35 of 38
13 Bibliography [1] ISO 7405, Dentistry -- Evaluation of biocompatibility of medical devices used in dentistry [2] GB/T , Quality management systems -- Fundamentals and vocabulary (GB/T , ISO 9000: 2000, IDT) [3] GB/T , Quality management systems -- Requirements (GB/T , ISO 9001: 2000, IDT) [4] GB/T , Managing for the sustained success of an organization -- A quality management approach (GB/T , ISO , IDT) [5] YY/T , Medical devices -- Quality management systems -- Requirements for regulatory purposes (YY/T , ISO 13485: 2003, IDT) [6] ISO/IEC 17025, General requirements for the competence of testing and calibration laboratories [7] Chemical Testing: OECD Guidelines for the Testing of Chemicals -- Section 4: Health Effects [8] Japan, Good Laboratory Practice for Preclinical Biological Tests of Medical devices; Ordinance of MHLW ( ) [9] USA, GLP reference in the Federal Register Page 37 of 38
14 Translation Reference and Original Chinese Standard [1] GB/T Biological evaluation of medical devices - Part 1: Evaluation and testing of the risk management process. Page 38 of 38
GB/T / ISO :2007
Translated English of Chinese Standard: GB/T16886.6-2015 www.chinesestandard.net Sales@ChineseStandard.net GB NATIONAL STANDARD OF THE PEOPLE'S REPUBLIC OF CHINA ICS 11.040.01 C 30 GB/T 16886.6-2015 /
More informationISO INTERNATIONAL STANDARD. Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process
INTERNATIONAL STANDARD ISO 10993-1 Fourth edition 2009-10-15 Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process Évaluation biologique des dispositifs
More informationISO INTERNATIONAL STANDARD. Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process
INTERNATIONAL STANDARD ISO 10993-1 Fourth edition 2009-10-15 Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process Évaluation biologique des dispositifs
More informationYY/T / ISO 13485:2003
Translated English of Chinese Standard: YY/T0287-2003 www.chinesestandard.net Sales@ChineseStandard.net YY ICS 11.040.01 C 30 PHARMACEUTICAL INDUSTRY STANDARD OF THE PEOPLE S REPUBLIC OF CHINA YY/T 0287-2003
More informationISO/TS TECHNICAL SPECIFICATION
TECHNICAL SPECIFICATION ISO/TS 10993-19 First edition 2006-06-01 Biological evaluation of medical devices Part 19: Physico-chemical, morphological and topographical characterization of materials Évaluation
More informationBiological evaluation of medical devices. Part 6: Tests for local effects after implantation
INTERNATIONAL STANDARD ISO 10993-6 Third edition 2016-12-01 Biological evaluation of medical devices Part 6: Tests for local effects after implantation Évaluation biologique des dispositifs médicaux Partie
More informationISO INTERNATIONAL STANDARD. Biological evaluation of medical devices Part 2: Animal welfare requirements
INTERNATIONAL STANDARD ISO 10993-2 Second edition 2006-07-15 Biological evaluation of medical devices Part 2: Animal welfare requirements Évaluation biologique des dispositifs médicaux Partie 2: Exigences
More informationYY/T / ISO 13485:2016
Translated English of Chinese Standard: YY/T0287-2017 www.chinesestandard.net Buy True-PDF Auto-delivery. Sales@ChineseStandard.net YY ICS 11.040.01; 03.120.10 C 30 PHARMACEUTICAL INDUSTRY STANDARD OF
More informationISO/TS TECHNICAL SPECIFICATION
TECHNICAL SPECIFICATION ISO/TS 10993-20 First edition 2006-08-01 Biological evaluation of medical devices Part 20: Principles and methods for immunotoxicology testing of medical devices Évaluation biologique
More informationISO INTERNATIONAL STANDARD. Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity
INTERNATIONAL STANDARD ISO 10993-5 Third edition 2009-06-01 Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity Évaluation biologique des dispositifs médicaux Partie 5: Essais
More informationRisk Management of Biological Evaluation What s the Future for ISO 10993?
Risk Management of Biological Evaluation What s the Future for ISO 10993? ISO 10993 High level guidance on how to conduct a biological evaluation Detailed test methods for investigation of different aspects
More informationBiocompatibility: a risk based approach
Biocompatibility: a risk based approach Legal framework The regulatory requirements include: Demonstration of safety Demonstration of efficacy Positive balance of risk and benefit The regulatory requirements
More informationFINAL DOCUMENT. Global Harmonization Task Force (revision of GHTF/SG1/N29:2005)
GHTF/SG1/N071:2012 FINAL DOCUMENT Global Harmonization Task Force (revision of GHTF/SG1/N29:2005) Title: Definition of the Terms Medical Device and In Vitro Diagnostic (IVD) Medical Device Authoring Group:
More informationISO INTERNATIONAL STANDARD. Biological evaluation of medical devices Part 17: Establishment of allowable limits for leachable substances
INTERNATIONAL STANDARD ISO 10993-17 First edition 2002-12-01 Biological evaluation of medical devices Part 17: Establishment of allowable limits for leachable substances Évaluation biologique des dispositifs
More informationOphthalmic optics - Contact lenses - Part 2: Rigid contact lenses specification
Translated English of Chinese Standard: GB11417.2-2012 www.chinesestandard.net Email: Sales@ChineseStandard.net GB ICS 11.040.70 C 40 NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA GB 11417.2-2012
More informationISO INTERNATIONAL STANDARD. Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process
INTERNATIONAL STANDARD ISO 10993-1 Fourth edition 2009-10-15 Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process Évaluation biologique des dispositifs
More informationGB / ISO :2006
Translated English of Chinese Standard: GB18281.1-2015 www.chinesestandard.net Sales@ChineseStandard.net ICS 11.080.01 C 47 NATIONAL STANDARD OF THE PEOPLE'S REPUBLIC OF CHINA GB / ISO 11138-1:2006 Replacing
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 10993-9 Second edition 2009-12-15 Biological evaluation of medical devices Part 9: Framework for identification and quantification of potential degradation products Évaluation
More informationISO : A Risked Based Approach to Biological Safety
ISO 10993 : A Risked Based Approach to Biological Safety Dr Arthur Brandwood Australian Delegation Leader to ISO TC 194 Biocompatibility and Clinical Trials Previous Director Devices Registration and Assessment
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. YY Translated English of Chinese Standard: YY0326.
Translated English of Chinese Standard: YY0326.2-2002 www.chinesestandard.net Sales@ChineseStandard.net Pharmaceutical Industry Standard of the People s Republic of China YY C 31 File No.: 9937-2002 Plasmapheresis
More informationYY/T INDUSTRY STANDARD OF THE PEOPLE S REPUBLIC OF CHINA
Translated English of Chinese Standard: YY/T1176-2010 Translated by: www.chinesestandard.net Wayne Zheng et al. Email: Sales@ChineseStandard.net ICS 11.100 YY C 44 INDUSTRY STANDARD OF THE PEOPLE S REPUBLIC
More informationYY Translated English of Chinese Standard: YY PHARMACEUTICAL INDUSTRY STANDARD
Translated English of Chinese Standard: YY 0762-2017 www.chinesestandard.net Buy True-PDF Auto-delivery. Sales@ChineseStandard.net YY PHARMACEUTICAL INDUSTRY STANDARD OF THE PEOPLE S REPUBLIC OF CHINA
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB
Translated English of Chinese Standard: GB18671-2009 www.chinesestandard.net Sales@ChineseStandard.net ICS 11.040.20 NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA GB C 31 Replacing GB 18671-2002
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 10993-13 Second edition 2010-06-15 Biological evaluation of medical devices Part 13: Identification and quantification of degradation products from polymeric medical devices
More informationTERMS AND DEFINITIONS
TERMS AND DEFINITIONS Advisory notice A notice issued by the organization, subsequent to delivery of the medical device, to provide supplementary information and/or to advise what action should be taken
More informationYY Translated English of Chinese Standard: YY NATIONAL STANDARD OF THE
Translated English of Chinese Standard: YY0847-2011 www.chinesestandard.net Sales@ChineseStandard.net NATIONAL STANDARD OF THE YY PEOPLE S REPUBLIC OF CHINA ICS 11.040.99 C 40 YY 0847-2011 Medical endoscopes
More informationMedical Device Testing. Andrew Makin, MSc, ERT, MRSB Scientific Director CiToxLAB Scantox, Denmark
Medical Device Testing Andrew Makin, MSc, ERT, MRSB Scientific Director CiToxLAB Scantox, Denmark Medical device Risk evaluation Efficacy Biocompatibility Clinical testing Pharmaceutical product Preclinical
More informationTITLE : Biological evaluation of medical devices-part 1: Evaluation and testing within a risk management process
DRAFTS IN WIDE CIRCULATION TECHNICAL COMMITTEE: MHD 19 DOCUMENT DESPATCH ADVICE Ref Date MHD 19/ T- 1,2,12,13,14 12/07/2012 ADDRESSED TO: 1. All members of Immuno-Biological Diagnostic Kits Sectional Committee,
More informationMedical Devices INNOVATIVE SOLUTION FOR THE HEALTHCARE
Medical Devices INNOVATIVE SOLUTION FOR THE HEALTHCARE Medical Devices The new Regulation 745/2017 defined as Medical Device any instrument, apparatus, appliance, software, implant, reagent, material or
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. YY Translated English of Chinese Standard: YY
Translated English of Chinese Standard: YY0903-2013 www.chinesestandard.net Sales@ChineseStandard.net PHARMACEUTICAL STANDARD YY OF THE PEOPLE S REPUBLIC OF CHINA ICS 11.040.60 C 42 Electroencephalographic
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 11737-2 Second edition 2009-11-15 Sterilization of medical devices Microbiological methods Part 2: Tests of sterility performed in the definition, validation and maintenance
More informationGB/T / ISO 527-2:1993
Translated English of Chinese Standard: GB/T1040.2-2006 www.chinesestandard.net Sales@ChineseStandard.net GB NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA ICS 83.080.01 G 31 GB/T 1040.2-2006 / ISO
More informationISO INTERNATIONAL STANDARD. Medical devices Quality management systems Requirements for regulatory purposes
INTERNATIONAL STANDARD ISO 13485 Second edition 2003-07-15 Medical devices Quality management systems Requirements for regulatory purposes Dispositifs médicaux Systèmes de management de la qualité Exigences
More informationGB/T / ISO 29767:2008
Translated English of Chinese Standard: GB/T30805-2014 www.chinesestandard.net Sales@ChineseStandard.net ICS 91.120.10 Q 25 NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA GB / ISO 29767:2008 Thermal
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB/T
Translated English of Chinese Standard: GB/T1540-2002 www.chinesestandard.net Sales@ChineseStandard.net GB ICS 85.060 Y 30 NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA neq ISO 535:1991 Paper and
More informationGreg LeBlanc Dir. Regulatory Affairs and Quality Systems Cook (Canada) Inc.
Greg LeBlanc Dir. Regulatory Affairs and Quality Systems Cook (Canada) Inc. ISO/TC 194 OVERVIEW Biological and clinical evaluation of medical devices Secretariat: DIN Secretary: Mr. Karl Wenzelewski Chairperson:
More informationGB/T / IEC :2006
Translated English of Chinese Standard: GB/T17646-2013 www.chinesestandard.net Sales@ChineseStandard.net NATIONAL STANDARD OF THE GB PEOPLE S REPUBLIC OF CHINA ICS 27.180 F 11 GB/T 17646-2013 / IEC 61400-2:2006
More informationGB/T / IEC :2006
Translated English of Chinese Standard: GB/T17646-2013 www.chinesestandard.net Sales@ChineseStandard.net NATIONAL STANDARD OF THE GB PEOPLE S REPUBLIC OF CHINA ICS 27.180 F 11 / IEC 61400-2:2006 Replacing
More informationMetallic materials Tensile testing at ambient temperature
Translated English of Chinese Standard: GB/T 228-2002 www.chinesestandard.net Email: Sales@ChineseStandard.net ICS 77.040.10 H 22 National Standard of the People's Republic of China GB GB/T 228-2002 eqv
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 10993-14 First edition 2001-11-15 Biological evaluation of medical devices Part 14: Identification and quantification of degradation products from ceramics Évaluation biologique
More informationISO INTERNATIONAL STANDARD. Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity
INTERNATIONAL STANDARD ISO 10993-5 Third edition 2009-06-01 Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity Évaluation biologique des dispositifs médicaux Partie 5: Essais
More information两系杂交水稻种子生产体系技术规范第 5 部分 : 种子纯度鉴定和不育系育性监测技术规范
Translated English of Chinese Standard: GB/T29371.5-2012 Translated by: www.chinesestandard.net Wayne Zheng et al. Email: Sales@ChineseStandard.net ICS 65.020.20 GB B 21 NATIONAL STANDARD OF THE PEOPLE
More informationISO 13485:2016 Quality Systems Manual
Documents are in Microsoft Word for ease of editing Insert Your Company Name/Logo Here ISO 13485:2016 Quality Systems Manual Document No. QMD-001 Street Address City, State / Province Zip / Postal code
More informationGB/T Translated English of Chinese Standard: GB/T
Translated English of Chinese Standard: GB/T223.82-2007 www.chinesestandard.net Sales@ChineseStandard.net NATIONAL STANDARD OF THE GB PEOPLE S REPUBLIC OF CHINA ICS 77.080.01 H 11 GB/T 223.82-2007 Steel
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB15193.
Translated English of Chinese Standard: GB15193.1-2003 www.chinesestandard.net Sales@ChineseStandard.net NATIONAL STANDARD OF THE GB PEOPLE S REPUBLIC OF CHINA ICS 07.100 C 53 Replacing GB 15193.1-1994
More informationIMDRF Project: List of international standards recognized by IMDRF management committee members. Progress Report
List of international standards recognized by IMDRF management committee members Progress Report Dr. Matthias Neumann Federal Ministry of Health, Germany Nice, 19 th of March 213 Mandate: 2 Steps IMDRF
More informationTesting and Evaluation Strategies for the Biological Evaluation of Medical Devices submitted for CE Mark and FDA Approval
Testing and Evaluation Strategies for the Biological Evaluation of Medical Devices submitted for CE Mark and FDA Approval Today, millions of medical devices are used worldwide to treat or support patients.
More informationMedical Device Single Audit Program (MDSAP)
Medical Device Single Audit Program (MDSAP) IMDRF MDSAP International Medical Device Regulators Forum Medical Device Single Audit Program IMDRF recognises that a global approach to auditing and monitoring
More informationMedical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS
Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,
More informationFINAL DOCUMENT. Definition of the Terms Medical Device and In Vitro Diagnostic (IVD) Medical Device. Work Group 1: Pre-market: General MD
AHWP/WG2-WG1/F001:2016 FINAL DOCUMENT Title: Authoring Group: Definition of the Terms Medical Device and In Vitro Diagnostic (IVD) Medical Device Work Group 2: Pre-market: IVDD & Work Group 1: Pre-market:
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB/T Translated English of Chinese Standard: GB/T4437.
Translated English of Chinese Standard: GB/T4437.2-2017 www.chinesestandard.net Buy True-PDF Auto-delivery. Sales@ChineseStandard.net ICS 77.150.10 NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA GB
More informationYY/T Translated English of Chinese Standard: YY/T
Translated English of Chinese Standard: YY/T0606.9-2007 www.chinesestandard.net Sales@ChineseStandard.net YY PHARMACEUTICAL INDUSTRY STANDARD OF THE PEOPLE S REPUBLIC OF CHINA ICS 11.040.40 C 45 YY/T 0606.9-2007
More informationOrganic Products Part 3: Labeling and Marketing
Translated English of Chinese Standard: GB/T19630.3-2011 Translated by: www.chinesestandard.net Wayne Zheng et al. Email: Sales@ChineseStandard.net ICS 65.020.01 B 04 NATIONAL STANDARD OF THE PEOPLE S
More informationCorrosion tests in artificial atmospheres
www.chinesestandard.net --> Buy GB/T True-PDF 10125-2012 --> Auto-delivered in 0~10 minutes. Translated English of Chinese Standard: GB/T10125-2012 Sales@ChineseStandard.net ICS 25.220.40 A 29 NATIONAL
More informationYY/T Translated English of Chinese Standard: YY/T PHARMACEUTICAL INDUSTRY STANDARD
Translated English of Chinese Standard: YY/T1470-2016 www.chinesestandard.net Buy True-PDF Auto-delivery. Sales@ChineseStandard.net PHARMACEUTICAL INDUSTRY STANDARD YY OF THE PEOPLE S REPUBLIC OF CHINA
More informationGB/T / ISO :2012
Translated English of Chinese Standard: GB/T26949.13-2017 www.chinesestandard.net Sales@ChineseStandard.net ICS 53.060 J 83 NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA GB / ISO 22915-13:2012 Industrial
More informationBridging gaps: medical device directive vs regulation. Geert Corstens 1 November 2018
Bridging gaps: medical device directive vs regulation Geert Corstens 1 November 2018 Agenda Current Medical Device regulatory landscape New Medical Device Regulation EU Interaction & impact Medical device
More informationDRUG DRAFT GUIDELINE FOR REGISTRATION OF MEDICAL DEVICES FOR HUMAN USE IN UGANDA, SEPTEMBER 2009
DRUG NATIONAL AUTHORITY DRAFT GUIDELINE FOR REGISTRATION OF MEDICAL DEVICES FOR HUMAN USE IN UGANDA, SEPTEMBER 2009 TABLE OF CONTENTS: 1 INTRODUCTION 2 DEFINITION OF MEDICAL DEVICE 3 SCOPE OF THE GUIDELINE
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB
Translated English of Chinese Standard: GB317-2006 www.chinesestandard.net Sales@ChineseStandard.net NATIONAL STANDARD OF THE GB PEOPLE S REPUBLIC OF CHINA ICS 71.100.60 X 44 Replacing GB 3861-1983 Food
More informationGB/T / ISO 22779:2006
Translated English of Chinese Standard: GB/T31566-2015 www.chinesestandard.net Sales@ChineseStandard.net GB NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA ICS 25.220.40 A 29 GB/T 31566-2015 / ISO
More informationGB/T Translated English of Chinese Standard: GB/T
Translated English of Chinese Standard: GB/T328.15-2007 www.chinesestandard.net Sales@ChineseStandard.net GB NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA ICS 91.120.30 Q 17 GB/T 328.15-2007 Test
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 11607-1 First edition 2006-04-15 Packaging for terminally sterilized medical devices Part 1: Requirements for materials, sterile barrier systems and packaging systems Emballages
More informationHow to Prepare MedDevice Packaging for Regulatory Success A Chemical Characterization (E&L) Perspective
How to Prepare MedDevice Packaging for Regulatory Success A Chemical Characterization (E&L) Perspective Frank Bieganousky, AMRI Wei Zhang, Ph.D., AMRI Purpose» Demonstrate a proactive approach for integration
More informationISO INTERNATIONAL STANDARD. Medical devices Quality management systems Requirements for regulatory purposes
INTERNATIONAL STANDARD ISO 13485 Second edition 2003-07-15 Medical devices Quality management systems Requirements for regulatory purposes Dispositifs médicaux Systèmes de management de la qualité Exigences
More informationYY Translated English of Chinese Standard: YY PHARMACEUTICAL INDUSTRY STANDARD
Translated English of Chinese Standard: YY 1293.5-2017 www.chinesestandard.net Buy True-PDF Auto-delivery. Sales@ChineseStandard.net PHARMACEUTICAL INDUSTRY STANDARD YY OF THE PEOPLE S REPUBLIC OF CHINA
More informationRegulations, Standards and Practices of Biocompatibility and Toxicology & Assessment in China
CFDA Jina Quality Suervision And Inspection Center For Medical Devices Shandong Quality Inspection Center for Medical Devices Regulations, Standards and Practices of Biocompatibility and Toxicology & Assessment
More informationGB/T Translated English of Chinese Standard: GB/T NATIONAL STANDARD OF THE
Translated English of Chinese Standard: GB/T27301-2008 www.chinesestandard.net Sales@ChineseStandard.net NATIONAL STANDARD OF THE GB PEOPLE S REPUBLIC OF CHINA ICS 67.040 X 00 GB/T 27301-2008 Food Safety
More informationDRUG REGISTRATION REGULATION
DRUG REGISTRATION REGULATION Registration Categories and Application Information Requirements of Chemical Drugs I Registration Categories 1) New chemical entity never marketed in any country. i. Drug substance
More informationChanges to the Regulation of IVDs in Europe. Copyright 2012 BSI. All rights reserved.
Changes to the Regulation of IVDs in Europe Copyright 2012 BSI. All rights reserved. Caution The new regulations are draft and subject to change Further details will be added later pre and post application
More informationAnnex 2: Registration Categories and Application Information Requirements of Chemical Drugs
Annex 2: Registration Categories and Application Information Requirements of Chemical Drugs I Registration Categories 1) New chemical entity never Launched in any country. i. Drug substance and its preparations
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 11135-1 First edition 2007-05-01 Sterilization of health care products Ethylene oxide Part 1: Requirements for development, validation and routine control of a sterilization
More informationGB/T / ISO :2009
Translated English of Chinese Standard: GB/T11348.4-2015 www.chinesestandard.net Sales@ChineseStandard.net GB NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA ICS 17.160 J 04 GB/T 11348.4-2015 / ISO
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB/T Translated English of Chinese Standard: GB/T3880.
Translated English of Chinese Standard: GB/T3880.3-2012 www.chinesestandard.net Sales@ChineseStandard.net ICS 77.150.10 NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA GB H 61 Replacing GB/T 3880.3-2006
More informationGB/T / IEC :1993
Translated English of Chinese Standard: GB/T2423.56-2006 www.chinesestandard.net Buy True-PDF Auto-delivery. Sales@ChineseStandard.net ICS 19.020 K 04 NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA
More informationGB/T Translated English of Chinese Standard: GB/T NATIONAL STANDARD OF
Translated English of Chinese Standard: GB/T18148-2015 www.chinesestandard.net Sales@ChineseStandard.net GB NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA ICS 53.100 P 97 GB/T 18148-2015 Replacing
More informationMedical devices utilizing animal tissues and their derivatives. Part 1: Application of risk management
Provläsningsexemplar / Preview INTERNATIONAL STANDARD ISO 22442-1 Second edition 2015-11-01 Medical devices utilizing animal tissues and their derivatives Part 1: Application of risk management Dispositifs
More informationGUIDANCE NOTE FOR MANUFACTURERS OF CUSTOM-MADE MEDICAL DEVICES
GUIDANCE NOTE FOR MANUFACTURERS OF CUSTOM-MADE MEDICAL DEVICES Foreword This guidance document is informative and advisory and has no legal authority. Individual national enforcement authorities are bound
More informationYY/T Translated English of Chinese Standard: YY/T PHARMACEUTICAL INDUSTRY STANDARD
Translated English of Chinese Standard: YY/T1288-2015 www.chinesestandard.net Buy True-PDF Auto-delivery. Sales@ChineseStandard.net PHARMACEUTICAL INDUSTRY STANDARD YY OF THE PEOPLE S REPUBLIC OF CHINA
More informationWhat can be done from regulatory side?
Federal Agency for Medicines and Health Products (FAMHP) What can be done from regulatory side? 9th Annual ecopa Workshop November 29-30, 2008, Brussels Dr. Sonja BEKEN Non-Clinical Assessor, Registration
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB/T Translated English of Chinese Standard: GB/T
Translated English of Chinese Standard: GB/T21331-2008 www.chinesestandard.net Buy True-PDF Auto-delivery. Sales@ChineseStandard.net ICS 85.040 NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA GB Y
More informationGB/T Translated English of Chinese Standard: GB/T NATIONAL STANDARD OF THE
Translated English of Chinese Standard: GB/T2059-2017 www.chinesestandard.net Sales@ChineseStandard.net GB NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA ICS 77.150.30 H 62 GB/T 2059-2017 Replacing
More informationSupplementary exam work (Number, form, scope) Courses (type of teaching) Contact time. Winter semester
READING VERSION OF MODULE DESCRIPTIONS The module descriptions are not part of the Regulations; they are integrated into the First Amendment to the Module Catalog. IEW-M1.1 Principles in Toxicology Number
More informationSupplementary exam work (Number, form, scope) Courses (type of teaching) Contact time. Winter semester
IEW-M1.1 Principles in Toxicology Number of credit points (CP): 12 Introduction to general toxicology Foundations of toxicokinetics (ADME: absorption, distribution, metabolism, and excretion) Foundations
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB/T Translated English of Chinese Standard: GB/T
Translated English of Chinese Standard: GB/T11354-2005 www.chinesestandard.net Sales@ChineseStandard.net NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA GB ICS 25.200 J 36 Replacing GB/T 11354-1989
More informationConformity Assessment of Medical Devices Under The New MDR
Conformity Assessment of Medical Devices Under The New MDR (Dec. 06, 2017) Tina Lochner, Medcert Slide 1 Agenda Scope: MDR Article 1 and 2 MDR Conformity Assessment: MHRA* (UK Competent Authority) MDR
More informationBiocompatible materials
Biocompatible materials 07.11.2011 Reactions of the human body on materials and components Effects of some metal ions Determination of biocompatibility by using in vitro and in vivo methods Non-metallic
More informationGB/T Translated English of Chinese Standard: GB/T NATIONAL STANDARD
Translated English of Chinese Standard: GB/T2912.1-2009 www.chinesestandard.net Sales@ChineseStandard.net ICS 59.080.01 W 04 GB NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA GB/T 2912.1-2009 Replacing
More informationMedical Device Regulatory Roadmap SAMED Conference 2-3 December 2015
Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015 Dr J. Gouws Registrar of Medicines Status in RSA: 2 December 2015 Legislation: Bill 6D, 2014 Defines MD and IVDs Licensing of Manufacturers,
More informationAccredited Laboratory
Accredited Laboratory A2LA has accredited St. Paul, MN for technical competence in the field of Biological Testing This laboratory is accredited in accordance with the recognized International Standard
More informationDue diligence in the European medical devices industry
Due diligence in the European medical devices industry Alison Dennis, Reed Smith LLP www.practicallaw.com/0-205-5707 As the medical devices industry is highly regulated, determining a target company's
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. SN/T
Translated English of Chinese Standard: SN/T2051-2008 www.chinesestandard.net Sales@ChineseStandard.net SN Entry-Exit Inspection and Quarantine Standards of the People s Republic of China Determination
More information--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB6675.
Translated English of Chinese Standard: GB6675.4-2014 www.chinesestandard.net Sales@ChineseStandard.net NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA GB ICS 97.200.50 Y 57 Partly replacing GB 6675-2003
More informationRegistration of Proprietary Chinese Medicine!
Registration of Proprietary Chinese Medicine! (Translation from Original Chinese Version) Product Safety Documents Technical Guidelines Table of Contents Page (A) Introduction 3 (B) Brief description of
More informationSAFETY RESEARCH INSTITUTE FOR CHEMICAL COMPOUNDS CO., LTD.
SAFETY RESEARCH INSTITUTE FOR CHEMICAL COMPOUNDS CO., LTD. HISTORICAL BACKGROUND I. PREDECESSOR CONCERN (SAFETY STUDY ASSOCIATION) The origin of our company is a group of researchers, Safety Study Association,
More informationMinimum Allowable Values of Energy Efficiency and Energy Efficiency Grades for Small and Medium Three-phase Asynchronous Motors
Translated English of Chinese Standard: GB18613-2012 Translated by: www.chinesestandard.net Wayne Zheng et al. Email: Wayne@ChineseStandard.net ICS 27.010 F 01 NATIONAL STANDARD OF THE PEOPLE'S REPUBLIC
More informationFINAL DOCUMENT. Global Harmonization Task Force. Title: Clinical Evidence for IVD medical devices Key Definitions and Concepts
GHTF/SG5/N6:2012 FINAL DOCUMENT Global Harmonization Task Force Title: Clinical Evidence for IVD medical devices Key Definitions and Concepts Authoring Group: Study Group 5 of the Global Harmonization
More informationJoint Replacement Implants Hip Joint Prostheses
Translated English of Chinese Standard: YY0118-2016 www.chinesestandard.net Sales@ChineseStandard.net PHARMACEUTICAL INDUSTRY STANDARD YY OF THE PEOPLE S REPUBLIC OF CHINA ICS 11.040.40 C 35 YY 0118-2016
More informationGB/T Translated English of Chinese Standard: GBT NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA
Translated English of Chinese Standard: GBT16294-2010 www.chinesestandard.net Buy True-PDF Auto-delivery. Sales@ChineseStandard.net GB NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA ICS 13.040.30
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 14160 First edition 1998-03-15 Sterilization of single-use medical devices incorporating materials of animal origin Validation and routine control of sterilization by liquid
More informationGB/T Translated English of Chinese Standard: GB/T
Translated English of Chinese Standard: GB/T11064.5-2013 www.chinesestandard.net Sales@ChineseStandard.net GB NATIONAL STANDARD OF THE PEOPLE S REPUBLIC OF CHINA ICS 77.120.99 H 64 GB/T 11064.5-2013 Replacing
More information